Logotype for Peak Rare Earths Limited

Peak Rare Earths (PEK) H2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Peak Rare Earths Limited

H2 2024 earnings summary

13 Jun, 2025

Executive summary

  • Loss after tax reduced to $18.2m for FY2024, down from $32.8m in FY2023, as pre-development and feasibility activities advanced for the Ngualla Rare Earth Project in Tanzania.

  • Net assets decreased to $70.1m from $88.9m, with working capital at $9.2m and cash of $7.6m at year-end.

  • Major milestones included a non-binding $96m funding and development term sheet with Shenghe, a binding offtake agreement, and a non-binding debt term sheet for US$176.6m.

  • Technical studies, early works, and a critical minerals exploration program confirmed high-grade mineralisation of phosphate, fluorspar, niobium, and rare earths.

  • No dividends declared or paid.

Financial highlights

  • Revenue was $957k (2023: $698k), mainly from interest and R&D rebates.

  • Loss after tax: $18.2m (2023: $32.8m); basic and diluted loss per share: 6.85 cents (2023: 15.38 cents).

  • Employee benefits expense: $4.0m (2023: $3.2m); technical feasibility costs: $8.7m (2023: $3.3m); exploration and evaluation costs: $1.3m (2023: nil).

  • Net cash outflow from operations: $17.4m; cash at year-end: $7.6m (2023: $25.9m).

  • No capital commitments or contingencies at year-end.

Outlook and guidance

  • Shenghe term sheet positions Ngualla as the only rare earth project globally with a complete offtake, development, and funding solution; Peak will not need to contribute further equity for project development upon completion.

  • Focus on finalising binding agreements with Shenghe and progressing project optimisation, cost reduction, and early works.

  • Sale of Teesside site expected to provide additional working capital.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more